{
"info": {
"nct_id": "NCT00319748",
"official_title": "Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers",
"inclusion_criteria": "* Adequate performance status:\n\n * Breast - Karnofsky score > 50;\n * Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2\n* If female and of childbearing potential, are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation.\n* Normal organ function within 14 days of study entry\n* Diagnosis of one of the following malignancies:\n\n * Metastatic breast cancer (BR)\n * Metastatic ovarian cancer (OV)\n * Metastatic endometrial cancer (EM)\n * Metastatic cervical cancer (CX)\n\nBreast Cancer Inclusion Criteria:\n\n* Measurable metastatic disease (>1cm) in at least one site other than bone-only\n* Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease\n* Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.\n\nOvarian Cancer Inclusion Criteria:\n\n* Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)\n* Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).\n* Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.\n\nEndometrial Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens\n\nCervical Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Had/have the following prior/concurrent therapy:\n\n * Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)\n * Investigational drugs/agents within 14 days of first dose of 852A\n * Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)\n * Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions\n * Radiotherapy within 3 weeks of the first dose of 852A\n * Hematopoietic cell transplantation within 4 weeks of first dose of 852A\n * Evidence of active infection within 3 days of first dose of 852A\n * Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)\n * Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication\n * History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk\n * Uncontrolled intercurrent or chronic illness\n * Active autoimmune disease requiring immunosuppressive therapy within 30 days\n * Active coagulation disorder not controlled with medication\n * Pregnant or lactating\n * Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated\n * Any history of brain metastases or any other active central nervous system (CNS) disease",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Adequate performance status:",
"criterions": [
{
"exact_snippets": [
"Adequate performance status"
],
"criterion": "performance status",
"requirement_type": "adequacy",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Adequate performance status"
],
"criterion": "performance status",
"requirement_type": "adequacy",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Breast - Karnofsky score > 50;",
"criterions": [
{
"exact_snippets": [
"Karnofsky score > 50"
],
"criterion": "Karnofsky score",
"requirement_type": "comparison",
"expected_value": {
"operator": ">",
"value": 50
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Karnofsky score > 50"
],
"criterion": "Karnofsky score",
"requirement_type": "comparison",
"expected_value": {
"operator": ">",
"value": 50
}
}
]
}
},
{
"identified_line": {
"line": "* Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2",
"criterions": [
{
"exact_snippets": [
"Ovarian, endometrial or cervical"
],
"criterion": "cancer type",
"requirement_type": "specific types",
"expected_value": [
"ovarian",
"endometrial",
"cervical"
]
},
{
"exact_snippets": [
"Gynecologic Oncology Group (GOG) performance score ≤2"
],
"criterion": "GOG performance score",
"requirement_type": "maximum value",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": [
"Ovarian, endometrial or cervical"
],
"criterion": "cancer type",
"requirement_type": "specific types",
"expected_value": [
"ovarian"
]
},
{
"exact_snippets": [
"Ovarian, endometrial or cervical"
],
"criterion": "cancer type",
"requirement_type": "specific types",
"expected_value": [
"endometrial"
]
},
{
"exact_snippets": [
"Ovarian, endometrial or cervical"
],
"criterion": "cancer type",
"requirement_type": "specific types",
"expected_value": [
"cervical"
]
}
]
},
{
"exact_snippets": [
"Gynecologic Oncology Group (GOG) performance score ≤2"
],
"criterion": "GOG performance score",
"requirement_type": "maximum value",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* If female and of childbearing potential, are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation.",
"criterions": [
{
"exact_snippets": [
"female"
],
"criterion": "gender",
"requirement_type": "specificity",
"expected_value": "female"
},
{
"exact_snippets": [
"childbearing potential"
],
"criterion": "childbearing potential",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"willing to use adequate contraception"
],
"criterion": "contraception use",
"requirement_type": "willingness",
"expected_value": true
},
{
"exact_snippets": [
"adequate contraception",
"hormonal, barrier method, abstinence"
],
"criterion": "contraception type",
"requirement_type": "specificity",
"expected_value": [
"hormonal",
"barrier method",
"abstinence"
]
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": [
"female"
],
"criterion": "gender",
"requirement_type": "specificity",
"expected_value": "female"
},
{
"exact_snippets": [
"childbearing potential"
],
"criterion": "childbearing potential",
"requirement_type": "presence",
"expected_value": true
}
]
},
"then_criteria": {
"and_criteria": [
{
"exact_snippets": [
"willing to use adequate contraception"
],
"criterion": "contraception use",
"requirement_type": "willingness",
"expected_value": true
},
{
"exact_snippets": [
"adequate contraception",
"hormonal, barrier method, abstinence"
],
"criterion": "contraception type",
"requirement_type": "specificity",
"expected_value": [
"hormonal",
"barrier method",
"abstinence"
]
}
]
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Normal organ function within 14 days of study entry",
"criterions": [
{
"exact_snippets": [
"Normal organ function"
],
"criterion": "organ function",
"requirement_type": "status",
"expected_value": "normal"
},
{
"exact_snippets": [
"within 14 days of study entry"
],
"criterion": "timeframe for organ function assessment",
"requirement_type": "timeframe",
"expected_value": "within 14 days of study entry"
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Normal organ function"
],
"criterion": "organ function",
"requirement_type": "status",
"expected_value": "normal"
},
{
"exact_snippets": [
"within 14 days of study entry"
],
"criterion": "timeframe for organ function assessment",
"requirement_type": "timeframe",
"expected_value": "within 14 days of study entry"
}
]
}
},
{
"identified_line": {
"line": "* Diagnosis of one of the following malignancies:",
"criterions": [
{
"exact_snippets": [
"Diagnosis of one of the following malignancies"
],
"criterion": "malignancy",
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Diagnosis of one of the following malignancies"
],
"criterion": "malignancy",
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Metastatic breast cancer (BR)",
"criterions": [
{
"exact_snippets": [
"Metastatic breast cancer"
],
"criterion": "breast cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Metastatic breast cancer"
],
"criterion": "breast cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Metastatic ovarian cancer (OV)",
"criterions": [
{
"exact_snippets": [
"Metastatic ovarian cancer"
],
"criterion": "ovarian cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Metastatic ovarian cancer"
],
"criterion": "ovarian cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Metastatic endometrial cancer (EM)",
"criterions": [
{
"exact_snippets": [
"Metastatic endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Metastatic endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Metastatic cervical cancer (CX)",
"criterions": [
{
"exact_snippets": [
"Metastatic cervical cancer"
],
"criterion": "cervical cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Metastatic cervical cancer"
],
"criterion": "cervical cancer",
"requirement_type": "metastasis",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "Breast Cancer Inclusion Criteria:",
"criterions": [
{
"exact_snippets": [
"Breast Cancer"
],
"criterion": "breast cancer",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Breast Cancer"
],
"criterion": "breast cancer",
"requirement_type": "presence",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Measurable metastatic disease (>1cm) in at least one site other than bone-only",
"criterions": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
},
{
"exact_snippets": [
"metastatic disease (>1cm)"
],
"criterion": "metastatic disease",
"requirement_type": "size",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 1
}
]
}
},
{
"exact_snippets": [
"at least one site other than bone-only"
],
"criterion": "metastatic disease site",
"requirement_type": "location",
"expected_value": "other than bone-only"
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
},
{
"exact_snippets": [
"metastatic disease (>1cm)"
],
"criterion": "metastatic disease",
"requirement_type": "size",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 1
}
]
}
}
]
},
{
"exact_snippets": [
"at least one site other than bone-only"
],
"criterion": "metastatic disease site",
"requirement_type": "location",
"expected_value": "other than bone-only"
}
]
}
},
{
"identified_line": {
"line": "* Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease",
"criterions": [
{
"exact_snippets": [
"Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease"
],
"criterion": "response to chemotherapy",
"requirement_type": "progression or failure",
"expected_value": true
},
{
"exact_snippets": [
"at least one previous chemotherapy regimen for metastatic disease"
],
"criterion": "previous chemotherapy regimen",
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease"
],
"criterion": "response to chemotherapy",
"requirement_type": "progression or failure",
"expected_value": true
},
{
"exact_snippets": [
"at least one previous chemotherapy regimen for metastatic disease"
],
"criterion": "previous chemotherapy regimen",
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1
}
}
]
}
},
{
"identified_line": {
"line": "Ovarian Cancer Inclusion Criteria:",
"criterions": [
{
"exact_snippets": [
"Ovarian Cancer"
],
"criterion": "ovarian cancer",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Ovarian Cancer"
],
"criterion": "ovarian cancer",
"requirement_type": "presence",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)",
"criterions": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
},
{
"exact_snippets": [
"Response Evaluation Criteria in Solid Tumors (RECIST)"
],
"criterion": "evaluation criteria",
"requirement_type": "type",
"expected_value": "RECIST"
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
},
{
"exact_snippets": [
"Response Evaluation Criteria in Solid Tumors (RECIST)"
],
"criterion": "evaluation criteria",
"requirement_type": "type",
"expected_value": "RECIST"
}
]
}
},
{
"identified_line": {
"line": "* Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).",
"criterions": [
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "epithelial ovarian cancer"
},
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either",
"fallopian tube cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "fallopian tube cancer"
},
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either",
"primary peritoneal cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "primary peritoneal cancer"
},
{
"exact_snippets": [
"not borderline or low malignant potential epithelial carcinoma"
],
"criterion": "primary tumor",
"requirement_type": "exclusion",
"expected_value": [
"borderline epithelial carcinoma",
"low malignant potential epithelial carcinoma"
]
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "epithelial ovarian cancer"
},
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either",
"fallopian tube cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "fallopian tube cancer"
},
{
"exact_snippets": [
"Primary tumor must have been diagnosed histologically as either",
"primary peritoneal cancer"
],
"criterion": "primary tumor",
"requirement_type": "histological diagnosis",
"expected_value": "primary peritoneal cancer"
}
]
},
{
"not_criteria": {
"exact_snippets": [
"not borderline or low malignant potential epithelial carcinoma"
],
"criterion": "primary tumor",
"requirement_type": "exclusion",
"expected_value": [
"borderline epithelial carcinoma",
"low malignant potential epithelial carcinoma"
]
}
}
]
}
},
{
"identified_line": {
"line": "* Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.",
"criterions": [
{
"exact_snippets": [
"failed at least two previous chemotherapy regimens"
],
"criterion": "previous chemotherapy regimens",
"requirement_type": "failure",
"expected_value": {
"operator": ">=",
"value": 2
}
},
{
"exact_snippets": [
"Paclitaxel must have been a component of one or both regimens"
],
"criterion": "Paclitaxel",
"requirement_type": "component of previous regimens",
"expected_value": true
},
{
"exact_snippets": [
"cisplatin or carboplatin must have been a component of one or both regimens"
],
"criterion": "cisplatin or carboplatin",
"requirement_type": "component of previous regimens",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"failed at least two previous chemotherapy regimens"
],
"criterion": "previous chemotherapy regimens",
"requirement_type": "failure",
"expected_value": {
"operator": ">=",
"value": 2
}
},
{
"exact_snippets": [
"Paclitaxel must have been a component of one or both regimens"
],
"criterion": "Paclitaxel",
"requirement_type": "component of previous regimens",
"expected_value": true
}
]
},
{
"and_criteria": [
{
"exact_snippets": [
"failed at least two previous chemotherapy regimens"
],
"criterion": "previous chemotherapy regimens",
"requirement_type": "failure",
"expected_value": {
"operator": ">=",
"value": 2
}
},
{
"exact_snippets": [
"cisplatin or carboplatin must have been a component of one or both regimens"
],
"criterion": "cisplatin or carboplatin",
"requirement_type": "component of previous regimens",
"expected_value": true
}
]
}
]
}
},
{
"identified_line": {
"line": "Endometrial Cancer Inclusion Criteria:",
"criterions": [
{
"exact_snippets": [
"Endometrial Cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Endometrial Cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "presence",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Measurable metastatic disease",
"criterions": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens",
"criterions": [
{
"exact_snippets": [
"Histologically proven recurrent or persistent endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "histological proof",
"expected_value": true
},
{
"exact_snippets": [
"recurrent or persistent endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "recurrence or persistence",
"expected_value": true
},
{
"exact_snippets": [
"not amenable to curative treatment with surgery and/or radiation therapy"
],
"criterion": "curative treatment with surgery and/or radiation therapy",
"requirement_type": "amenability",
"expected_value": false
},
{
"exact_snippets": [
"has failed 2 previous treatment regimens"
],
"criterion": "previous treatment regimens",
"requirement_type": "failure",
"expected_value": true
},
{
"exact_snippets": [
"failed 2 previous treatment regimens"
],
"criterion": "number of previous treatment regimens",
"requirement_type": "count",
"expected_value": {
"operator": "=",
"value": 2
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Histologically proven recurrent or persistent endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "histological proof",
"expected_value": true
},
{
"exact_snippets": [
"recurrent or persistent endometrial cancer"
],
"criterion": "endometrial cancer",
"requirement_type": "recurrence or persistence",
"expected_value": true
}
]
},
{
"exact_snippets": [
"not amenable to curative treatment with surgery and/or radiation therapy"
],
"criterion": "curative treatment with surgery and/or radiation therapy",
"requirement_type": "amenability",
"expected_value": false
},
{
"and_criteria": [
{
"exact_snippets": [
"has failed 2 previous treatment regimens"
],
"criterion": "previous treatment regimens",
"requirement_type": "failure",
"expected_value": true
},
{
"exact_snippets": [
"failed 2 previous treatment regimens"
],
"criterion": "number of previous treatment regimens",
"requirement_type": "count",
"expected_value": {
"operator": "=",
"value": 2
}
}
]
}
]
}
},
{
"identified_line": {
"line": "Cervical Cancer Inclusion Criteria:",
"criterions": [
{
"exact_snippets": [
"Cervical Cancer"
],
"criterion": "cervical cancer",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Cervical Cancer"
],
"criterion": "cervical cancer",
"requirement_type": "presence",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Measurable metastatic disease",
"criterions": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Measurable metastatic disease"
],
"criterion": "metastatic disease",
"requirement_type": "measurability",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens.",
"criterions": [
{
"exact_snippets": [
"Histologically proven"
],
"criterion": "histological proof",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix"
],
"criterion": "cervical carcinoma",
"requirement_type": "type",
"expected_value": [
"squamous cell carcinoma",
"adenosquamous carcinoma",
"adenocarcinoma"
]
},
{
"exact_snippets": [
"not amenable to curative treatment with surgery and/or radiation therapy"
],
"criterion": "curative treatment",
"requirement_type": "amenability",
"expected_value": false
},
{
"exact_snippets": [
"has failed 2 previous treatment regimens"
],
"criterion": "previous treatment regimens",
"requirement_type": "failure",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Histologically proven"
],
"criterion": "histological proof",
"requirement_type": "presence",
"expected_value": true
},
{
"or_criteria": [
{
"exact_snippets": [
"recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix"
],
"criterion": "cervical carcinoma",
"requirement_type": "type",
"expected_value": "squamous cell carcinoma"
},
{
"exact_snippets": [
"recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix"
],
"criterion": "cervical carcinoma",
"requirement_type": "type",
"expected_value": "adenosquamous carcinoma"
},
{
"exact_snippets": [
"recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix"
],
"criterion": "cervical carcinoma",
"requirement_type": "type",
"expected_value": "adenocarcinoma"
}
]
}
]
},
{
"exact_snippets": [
"not amenable to curative treatment with surgery and/or radiation therapy"
],
"criterion": "curative treatment",
"requirement_type": "amenability",
"expected_value": false
},
{
"exact_snippets": [
"has failed 2 previous treatment regimens"
],
"criterion": "previous treatment regimens",
"requirement_type": "failure",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Had/have the following prior/concurrent therapy:",
"criterions": [
{
"exact_snippets": [
"Had/have the following prior/concurrent therapy"
],
"criterion": "prior/concurrent therapy",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": [
"Had/have the following prior/concurrent therapy"
],
"criterion": "prior/concurrent therapy",
"requirement_type": "presence",
"expected_value": true
}
}
},
{
"identified_line": {
"line": "* Investigational drugs/agents within 14 days of first dose of 852A",
"criterions": [
{
"exact_snippets": [
"Investigational drugs/agents within 14 days of first dose of 852A"
],
"criterion": "investigational drugs/agents",
"requirement_type": "time since last dose",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 14
}
]
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": [
"Investigational drugs/agents within 14 days of first dose of 852A"
],
"criterion": "investigational drugs/agents",
"requirement_type": "time since last dose",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 14
}
]
}
}
}
},
{
"identified_line": {
"line": "* Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)",
"criterions": [
{
"exact_snippets": [
"Immunosuppressive therapy"
],
"criterion": "immunosuppressive therapy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"cytotoxic agents within 14 days of first dose of 852A"
],
"criterion": "cytotoxic agents",
"requirement_type": "time since last administration",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 14
}
]
}
},
{
"exact_snippets": [
"nitrosoureas within 30 days of first dose"
],
"criterion": "nitrosoureas",
"requirement_type": "time since last administration",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 30
}
]
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Immunosuppressive therapy"
],
"criterion": "immunosuppressive therapy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"cytotoxic agents within 14 days of first dose of 852A"
],
"criterion": "cytotoxic agents",
"requirement_type": "time since last administration",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 14
}
]
}
}
]
},
{
"exact_snippets": [
"nitrosoureas within 30 days of first dose"
],
"criterion": "nitrosoureas",
"requirement_type": "time since last administration",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 30
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions",
"criterions": [
{
"exact_snippets": [
"Drugs known to induce QT interval prolongation"
],
"criterion": "drugs",
"requirement_type": "induction of QT interval prolongation",
"expected_value": true
},
{
"exact_snippets": [
"Drugs known to",
"induce Torsades de pointes"
],
"criterion": "drugs",
"requirement_type": "induction of Torsades de pointes",
"expected_value": true
}
]
},
"logical_structure": {
"condition": {
"or_criteria": [
{
"exact_snippets": [
"Drugs known to induce QT interval prolongation"
],
"criterion": "drugs",
"requirement_type": "induction of QT interval prolongation",
"expected_value": true
},
{
"exact_snippets": [
"Drugs known to",
"induce Torsades de pointes"
],
"criterion": "drugs",
"requirement_type": "induction of Torsades de pointes",
"expected_value": true
}
]
},
"then_criteria": {
"not_criteria": {
"exact_snippets": [
"best available drug required to treat life-threatening conditions"
],
"criterion": "best available drug",
"requirement_type": "necessity for life-threatening conditions",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Radiotherapy within 3 weeks of the first dose of 852A",
"criterions": [
{
"exact_snippets": [
"Radiotherapy within 3 weeks"
],
"criterion": "radiotherapy",
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3
}
]
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": [
"Radiotherapy within 3 weeks"
],
"criterion": "radiotherapy",
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3
}
]
}
}
}
},
{
"identified_line": {
"line": "* Hematopoietic cell transplantation within 4 weeks of first dose of 852A",
"criterions": [
{
"exact_snippets": [
"Hematopoietic cell transplantation within 4 weeks of first dose of 852A"
],
"criterion": "hematopoietic cell transplantation",
"requirement_type": "time since",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4
}
]
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": [
"Hematopoietic cell transplantation within 4 weeks of first dose of 852A"
],
"criterion": "hematopoietic cell transplantation",
"requirement_type": "time since",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4
}
]
}
}
}
},
{
"identified_line": {
"line": "* Evidence of active infection within 3 days of first dose of 852A",
"criterions": [
{
"exact_snippets": [
"Evidence of active infection"
],
"criterion": "active infection",
"requirement_type": "evidence",
"expected_value": true
},
{
"exact_snippets": [
"within 3 days of first dose"
],
"criterion": "time since first dose",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Evidence of active infection"
],
"criterion": "active infection",
"requirement_type": "evidence",
"expected_value": true
},
{
"exact_snippets": [
"within 3 days of first dose"
],
"criterion": "time since first dose",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)",
"criterions": [
{
"exact_snippets": [
"Active fungal infection"
],
"criterion": "fungal infection",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"pulmonary infiltrates"
],
"criterion": "pulmonary infiltrates",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Active fungal infection"
],
"criterion": "fungal infection",
"requirement_type": "activity",
"expected_value": true
},
{
"not_criteria": {
"exact_snippets": [
"prior treated disease stable for 2 weeks is allowable"
],
"criterion": "disease stability",
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 2
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": [
"pulmonary infiltrates"
],
"criterion": "pulmonary infiltrates",
"requirement_type": "presence",
"expected_value": true
},
{
"not_criteria": {
"exact_snippets": [
"prior treated disease stable for 2 weeks is allowable"
],
"criterion": "disease stability",
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 2
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication",
"criterions": [
{
"exact_snippets": [
"Cardiac ischemia"
],
"criterion": "cardiac ischemia",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"cardiac arrhythmias"
],
"criterion": "cardiac arrhythmias",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"congestive heart failure uncontrolled by medication"
],
"criterion": "congestive heart failure",
"requirement_type": "control",
"expected_value": false
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": [
"Cardiac ischemia"
],
"criterion": "cardiac ischemia",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"cardiac arrhythmias"
],
"criterion": "cardiac arrhythmias",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"congestive heart failure uncontrolled by medication"
],
"criterion": "congestive heart failure",
"requirement_type": "control",
"expected_value": false
}
]
}
},
{
"identified_line": {
"line": "* History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk",
"criterions": [
{
"exact_snippets": [
"History of, or clinical evidence of, a condition"
],
"criterion": "condition",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"in the opinion of the investigator, could confound the results of the study"
],
"criterion": "condition",
"requirement_type": "potential to confound study results",
"expected_value": true
},
{
"exact_snippets": [
"in the opinion of the investigator,",
"put the subject at undue risk"
],
"criterion": "condition",
"requirement_type": "potential to put subject at risk",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"History of, or clinical evidence of, a condition"
],
"criterion": "condition",
"requirement_type": "presence",
"expected_value": true
},
{
"or_criteria": [
{
"exact_snippets": [
"in the opinion of the investigator, could confound the results of the study"
],
"criterion": "condition",
"requirement_type": "potential to confound study results",
"expected_value": true
},
{
"exact_snippets": [
"in the opinion of the investigator,",
"put the subject at undue risk"
],
"criterion": "condition",
"requirement_type": "potential to put subject at risk",
"expected_value": true
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Uncontrolled intercurrent or chronic illness",
"criterions": [
{
"exact_snippets": [
"Uncontrolled intercurrent or chronic illness"
],
"criterion": "intercurrent illness",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"Uncontrolled intercurrent or chronic illness"
],
"criterion": "chronic illness",
"requirement_type": "control",
"expected_value": false
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": [
"Uncontrolled intercurrent or chronic illness"
],
"criterion": "intercurrent illness",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"Uncontrolled intercurrent or chronic illness"
],
"criterion": "chronic illness",
"requirement_type": "control",
"expected_value": false
}
]
}
},
{
"identified_line": {
"line": "* Active autoimmune disease requiring immunosuppressive therapy within 30 days",
"criterions": [
{
"exact_snippets": [
"Active autoimmune disease"
],
"criterion": "autoimmune disease",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"requiring immunosuppressive therapy"
],
"criterion": "immunosuppressive therapy",
"requirement_type": "requirement",
"expected_value": true
},
{
"exact_snippets": [
"within 30 days"
],
"criterion": "time since last immunosuppressive therapy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 30
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"Active autoimmune disease"
],
"criterion": "autoimmune disease",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"requiring immunosuppressive therapy"
],
"criterion": "immunosuppressive therapy",
"requirement_type": "requirement",
"expected_value": true
}
]
},
{
"exact_snippets": [
"within 30 days"
],
"criterion": "time since last immunosuppressive therapy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 30
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Active coagulation disorder not controlled with medication",
"criterions": [
{
"exact_snippets": [
"Active coagulation disorder"
],
"criterion": "coagulation disorder",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"not controlled with medication"
],
"criterion": "coagulation disorder",
"requirement_type": "control with medication",
"expected_value": false
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Active coagulation disorder"
],
"criterion": "coagulation disorder",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"not controlled with medication"
],
"criterion": "coagulation disorder",
"requirement_type": "control with medication",
"expected_value": false
}
]
}
},
{
"identified_line": {
"line": "* Pregnant or lactating",
"criterions": [
{
"exact_snippets": [
"Pregnant"
],
"criterion": "pregnancy",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"lactating"
],
"criterion": "lactation",
"requirement_type": "status",
"expected_value": true
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": [
"Pregnant"
],
"criterion": "pregnancy",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"lactating"
],
"criterion": "lactation",
"requirement_type": "status",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "* Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated",
"criterions": [
{
"exact_snippets": [
"Concurrent malignancy"
],
"criterion": "concurrent malignancy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"if in remission, at least 5 years disease free"
],
"criterion": "remission duration",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"localized (in-situ) disease"
],
"criterion": "localized (in-situ) disease",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"basal carcinomas"
],
"criterion": "basal carcinomas",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"cutaneous squamous cell carcinomas"
],
"criterion": "cutaneous squamous cell carcinomas",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"adequately treated"
],
"criterion": "adequate treatment",
"requirement_type": "status",
"expected_value": true
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"not_criteria": {
"exact_snippets": [
"Concurrent malignancy"
],
"criterion": "concurrent malignancy",
"requirement_type": "presence",
"expected_value": false
}
},
{
"or_criteria": [
{
"exact_snippets": [
"localized (in-situ) disease"
],
"criterion": "localized (in-situ) disease",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"basal carcinomas"
],
"criterion": "basal carcinomas",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"cutaneous squamous cell carcinomas"
],
"criterion": "cutaneous squamous cell carcinomas",
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
"then_criteria": {
"exact_snippets": [
"adequately treated"
],
"criterion": "adequate treatment",
"requirement_type": "status",
"expected_value": true
},
"else_criteria": {
"exact_snippets": [
"if in remission, at least 5 years disease free"
],
"criterion": "remission duration",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
}
}
},
{
"identified_line": {
"line": "* Any history of brain metastases or any other active central nervous system (CNS) disease",
"criterions": [
{
"exact_snippets": [
"history of brain metastases"
],
"criterion": "brain metastases",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"active central nervous system (CNS) disease"
],
"criterion": "central nervous system (CNS) disease",
"requirement_type": "activity",
"expected_value": true
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": [
"history of brain metastases"
],
"criterion": "brain metastases",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"active central nervous system (CNS) disease"
],
"criterion": "central nervous system (CNS) disease",
"requirement_type": "activity",
"expected_value": true
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.",
"criterions": [
{
"exact_snippets": [
"Progression on prior therapy with a hormonal agent",
"estrogen receptor or progesterone receptor positive"
],
"criterion": "hormonal therapy",
"requirement_type": "progression",
"expected_value": true
},
{
"exact_snippets": [
"estrogen receptor or progesterone receptor positive"
],
"criterion": "estrogen receptor or progesterone receptor",
"requirement_type": "status",
"expected_value": "positive"
},
{
"exact_snippets": [
"Progression on prior therapy",
"trastuzumab",
"HER2-neu positive"
],
"criterion": "trastuzumab therapy",
"requirement_type": "progression",
"expected_value": true
},
{
"exact_snippets": [
"HER2-neu positive"
],
"criterion": "HER2-neu",
"requirement_type": "status",
"expected_value": "positive"
},
{
"exact_snippets": [
"progressed through hormone or trastuzumab therapy only",
"must have received one chemotherapy regimen"
],
"criterion": "chemotherapy regimen",
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1
}
}
]
},
"logical_structure": {
"exact_snippets": [
"failed"
],
"criterion": "failed",
"requirement_type": "failed",
"expected_value": "failed"
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)",
"criterions": [
{
"exact_snippets": [
"Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A"
],
"criterion": "systemic corticosteroids",
"requirement_type": "usage",
"expected_value": false
},
{
"exact_snippets": [
"topical or inhaled steroids are allowed"
],
"criterion": "topical or inhaled steroids",
"requirement_type": "usage",
"expected_value": true
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": [
"Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A"
],
"criterion": "systemic corticosteroids",
"requirement_type": "usage",
"expected_value": true
}
]
},
"then_criteria": {
"not_criteria": {
"exact_snippets": [
"Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A"
],
"criterion": "systemic corticosteroids",
"requirement_type": "usage",
"expected_value": false
}
},
"else_criteria": null
}
}
],
"failed_miscellaneous": []
}